CD274 and neoplasm: Anti-PD-L1 antibodies bind to PD-L1 proteins, inhibit the link between PD-1 and PD-L1, and may mediate antibody-dependent cellular cytotoxicity of natural killer cells (via Fc receptors for IgG) as well as activation of dendritic cells which in turn activate anti-tumour T-cell induced immune response.